Antiaging medicine: The good, the bad, and the ugly

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 57, Issue 10, 2002, Pages

  Fisher, Alfred ^a   Morley, John E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; ESTROGEN; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN; HYPERICUM PERFORATUM EXTRACT; NICOTINIC ACID; PRASTERONE; PREGNENOLONE; SIMVASTATIN; SOMATOMEDIN C; TESTOSTERONE;

AGING; ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CALORIC RESTRICTION; CANCER PREVENTION; CLINICAL TRIAL; DEPRESSION; DIET SUPPLEMENTATION; DRUG ANTAGONISM; DRUG EFFECT; EDITORIAL; EVIDENCE BASED MEDICINE; EXERCISE; HORMONE SUBSTITUTION; HUMAN; HYPERICUM PERFORATUM; LONGEVITY; OXIDATIVE STRESS; PRIORITY JOURNAL; QUALITY OF LIFE;

HYPERICUM; HYPERICUM PERFORATUM;

EID: 0036785360     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/57.10.M636     Document Type: Editorial

References (95)

1. Chase P, Mitchell K, Morley JE. In the steps of giants: the early geriatrics texts. J Am Geriatr Soc. 2000;48:89-94.
2. Hercberg S, Galan P, Preziosi P, Alfarez MJ, Vazquez C. The potential role of antioxidant vitamins in preventing cardiovascular diseases and cancers. Nutrition. 1998;14:513-520.
3. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature. 1998;392:559.
4. Yu BP. Approaches to anti-aging intervention: the promises and the uncertainties. Mech Ageing Dev. 1999;111:73-87.
5. Guarente L, Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature. 2000;408:255-262.
6. Vettraino J, Buck S, Arking R. Direct selection of paraquat resistance in Drosophila results in a different extended longevity phenotype. J Gerontol Biol Sci. 2001;56A:B415-B425.
7. Huang TT, Carlson EJ, Gillespie AM, Shi YP, Epstein CJ. Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in mice. J Gerontol Biol Sci. 2000;55A:B5-B9.
8. Vitolins MZ, Quandt SA, Case LD, Bell RA, Arcury TA, McDonald J. Vitamin and mineral supplement use by older rural adults. J Gerontol Med Sci. 2000;55A:M613-M617.
9. Ness A, Smith GD. Mortality in the CHAOS trial. Cambridge Heart Antioxidant Study. Lancet. 1999;353:1017-1018.
10. Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Lancet. 2001;357:89-95.
11. Bunout D. Therapeutic potential of vitamin E in heart disease. Expert Opinion Investig Drugs. 2000;9:2629-2635.
12. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154-160.
13. Valagussa F, Franzosi MG, Geraci E, et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447-455.
14. Lonn E, Yusuf S, Dzavik V, et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation. 2001;103:919-925.
15. Willett WC, Stampfer MJ. What vitamins should I be taking doctor? N Engl J Med. 2001;345:1819-1823.
16. Brown BG, Zhao XQ, Chair A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583-1592.
17. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 1997;336:1216-1222.
18. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994; 330:1029-1035.
19. Feskanich D, Singh V, Willett WC, Colditz GA. Vitamin A intake and hip fractures among postmenopausal women. JAMA. 2002;287:47-54.
20. Stoll S, Hartmann H, Cohen SA, Muller WE. The potent free radical scavenger alpha-lipoic acid improves memory in aged mice: putative relationship to NMDA receptor deficits. Pharmacol Biochem Behav. 1993;46:799-805.
21. Morley JE, Kumar VB, Bernardo AE, et al. Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides. 2000;21:1761-1767.
22. Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 1995;38:1425-1433.
23. Allison DB, Miller RA, Austad SN, et al. Genetic variability in responses to caloric restriction in animals and in regulation of metabolism and obesity in humans. J Gerontol Biol Sci Med Sci. 2001; 56A(Special Issue I):55-65.
24. Haldey EC, Dutta C, Finkelstein J, et al. Human implications of caloric restriction's effects on aging in laboratory animals: an overview of opportunities for research. J Gerontol Biol Sci Med Sci. 2001; 56A(Special Issue I):5-6.
25. Lee I-M, Blair SN, Allison DB, et al. Epidemiologic data on the relationships of caloric intake, energy balance, and weight gain over the life span with longevity and morbidity. J Gerontol Biol Sci Med Sci. 2001;56A(Special Issue I):7-19.
26. Poehlman ET, Turturro A, Bodkin N, et al. Caloric restriction mimetics: physical activity and body composition changes. J Gerontol Biol Sci Med Sci. 2001;56A(Special Issue I):45-54.
27. Banks WA, Phillips-Controy JE, Jolly CJ, Morley JE. Serum leptin levels in wild and captive populations of baboons (papio): implications for the ancestral role of leptin. J Clin Endocrinol Metab. 2001;86:4315-4320.
28. Roberts SB, Pi-Sunyer X, Kuller L, et al. Physiologic effects of lowering caloric intake in nonhuman primates and nonobese humans. J Gerontol Biol Sci Med Sci. 2001;56A(Special Issue I):66-75.
29. Mobbs CV, Bray GA, Atkinson RL, et al. Neuroendocrine and pharmacological manipulations to assess how caloric restriction increases life span. J Gerontol Biol Sci Med Sci. 2001;56A(Special Issue I):34-44.
30. Morley JE. Decreased food intake with aging. J Gerontol A Biol Sci Med Sci. 2001;56A(Special Issue II):81-88.
31. Amarantos E, Martinez A, Dwyer J. Nutrition and quality of life in older adults. J Gerontol Biol Sci Med Sci. 2001;56A(Special Issue II): 54-64.
32. Zuliani G, Romagnoni F, Volpato S, et al. Nutritional parameters, body composition, and progression of disability in older disabled residents living in nursing homes. J Gerontol Med Sci. 2001;56A:M212-M216.
33. Roberts SB, Fuss P, Heyman MB, et al. Control of food intake in older men. JAMA. 1994;272:1601-1606.
34. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001;137:231-243.
35. Weindruch R, Keenan KP, Carney JM, et al. Caloric restriction mimetics: metabolic interventions. J Gerontol Biol Sci Med Sci. 2001; 56A(Special Issue I):20-33.
36. Meneilly GS, Tessier D. Diabetes in elderly adults. J Gerontol Med Sci. 2001;56A:M5-M13.
37. Morley JE, Unterman TG, Hormonal fountains of youth. J Lab Clin Med. 2000;135:364-366.
38. Manson JE, Martin KA. Clinical practice: postmenopausal hormone replacement therapy. N Engl J Med. 2001:345:34-40.
39. Wells G, Herrington DM. The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain? Drugs Aging. 1999;15:419-422.
40. Fitzpatrick LA, Litin SC, Bell MR. The Women's Health Initiative: a heart-to-HRT conversation. Mayo Clin Proc. 2000;75:559-561.
41. Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol Med Sci. 2002;57A:M76-M99.
42. Morley JE, Kaiser FE, Perry HM 3rd, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 1997;46:410-413.
43. Morley JE. Andropause: is it time for the geriatrician to treat it? J Gerontol Med Sci. 2001;56A:M263-M265.
44. Morley JE. Androgens and aging [review]. Maturitas. 2001;38:61-71.
45. Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab. 1999;84:2647-2653.
46. Sih R, Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab. 1997;82:1661-1667.
47. Tenover JL. Male hormone replacement therapy including "andropause." Endocrinol Metab Clin North Am. 1998;27:969-987.
48. Morley JE, Perry HM 3rd, Kaiser FE, et al. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc. 1993;41:149-152.
49. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol Med Sci. 2001; 56A:M266-M272.
50. Perry HM 3rd, Miller DK, Patrick P, Morley JE. Testosterone and leptin in older African-American men: relationship to age, strength function, and season. Metabolism. 2000;49:1085-1091.
51. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Med Sci. 2001;56A:M146-M156.
52. Hamilton JB, Mestler GE. Mortality and survival: comparison of eunuchs with intact men and women in mentally retarded population. J Gerontol. 1969;24:394-411.
53. Nieschlag E, Neischlag S, Behre HM. Lifespan and testosterone. Nature. 1993;366(6452):215.
54. Morley JE, Perry HM 3rd. Androgen deficiency in aging men: role of testosterone replacement therapy. J Lab Clin Med. 2000;135:370-378.
55. Davis SR, Burger HG. Use of androgens in postmenopausal women. Curr Opin Obstet Gynecol. 1997;9:177-180.
56. Morley JE, Kaiser F, Raum WJ, et al. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci USA. 1997;94:7537-7542.
57. Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci USA. 2000;97:4279-4284.
58. Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SSC. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol. 1998;49:421-432.
59. Flood JF, Morley JE, Roberts E. Pregnenolone sulfate enhances posttraining memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive. Proc Natl Acad Sci USA. 1995;92:10806-10810.
60. Flood JF, Morley JE, Roberts E. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci USA. 1992;89:1567-1571.
61. Sih R, Kamel H, Horani H, Morley JE. Dehydroepiandrosterone and pregenolone. In: Meikle AW, ed. Hormone Replacement Therapy. Totowa, NJ: Humana Press: 1999:241-262.
62. Anawalt BD, Merriam GR. Neuroendocrine aging in men. Andropause and somatopause. Endocrinol Metab Clin North Am. 2001;30: 647-669.
63. Ravalgia G, Forti P, Maioli F, et al. Body composition, sex steroids, IGF-1, and bone mineral status in aging men. J Gerontol Med Sci. 2000;55A:M516-M521.
64. Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990;323:1-6.
65. Johannsson G, Svensson J, Bengtsson BA. Growth hormone and ageing. Growth Hormone Igf Res. 2000;10(suppl B):S25-S30.
66. von Werder K. The somatopause is no indication for growth hormone therapy. J Endocrinol Invest. 1999;22(suppl 5):137-141.
67. Christmas C, O'Connor KG, Harman SM, et al. Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men. J Gerontol Med Sci. 2002;57A:M12- M18.
68. Bartke A, Coshigano K, Kopchick J, et al. Genes that prolong life: relationships of growth hormone and growth to aging and life span. J Gerontol Biol Sci. 2001;56A:B340-B349.
69. Hauck SJ, Bartke A. Free radical defenses in the liver and kidney of human growth hormone transgenic mice: possible mechanisms of early mortality. J Gerontol Biol Sci. 2001;56A:B153-B162.
70. Ernst E. The risk-benefit profile of commonly used herbal therapies: ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava. Ann Intern Med. 2002;136:42-53.
71. Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St. John's Wort) in major depressive disorder: a randomized controlled trial. JAMA. 2002;287:1807-1814.
72. Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA. Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med. 2001;161:813-824.
73. Fleischauer AT, Arab L. Garlic and cancer: a critical review of the epidemiologic literature. J Nutr. 2001;131:1032S-1040S.
74. Gonzalez RP, Leyva A, Morales MO. Shark cartilage as source of antiangiogenic compounds: from basic to clinical research. Biol Pharm Bull. 2001;24:1097-1101.
75. Metchnikoff E. The prolongation of life. Optimistic Studies. London: Butterworth-Heinemann; 1907.
76. Schaafsma G. State of art concerning probiotic strains in milk products. IDF Nutr Newsletter. 1996;5:23-24.
77. Kopp-Hoolihan L. Prophylactic and therapeutic uses of probiotoics: a review. J Am Diet Assoc. 2001;101:229-238.
78. Saavedra JM. Clinical applications of probiotic agents. Am J Clin Nutr. 2001;73(suppl):1147S-1151S.
79. Foster DF, Phillips RS, Hamel MB, Eisenberg DM. Alternative medicine use in older Americans. J Am Geriatr Soc. 2000;48:1560-1565.
80. Loera JA, Black SA, Markides KS, Espino DV, Goodwin JS. The use of herbal medicine by older Mexican Americans. J Gerontol Med Sci. 2001;56A:M714-M718.
81. Astin JA, Pelletier KR, Marie A, Haskell WL. Complementary and alternative medicine use among elderly persons: one-year analysis of a Blue Shield Medicare Supplement. J Gerontol Med Sci. 2000;55A: M4-M9.
82. Flaherty JH, Takahashi R, Teoh J, et al. Use of alternative therapies in older outpatients in the United States and Japan: prevalence, reporting patterns, and perceived effectiveness. J Gerontol Med Sci. 2001;56A: M650-M655.
83. Fiatarone-Singh MA. Exercise comes of age: rationale and recommendations for a geriatric exercise prescription. J Gerontol Med Sci. 2002; 57A:M262-M282.
84. Evans WJ. Exercise strategies should be designed to increase muscle power. J Gerontol Med Sci. 2000;55A:M309-M310.
85. Westerterp KR, Meijer EP, Physical activity and parameters of aging: a physiological perspective. J Gerontol Biol Sci Med Sci. 2001; 56A(Special Issue II):7-12.
86. Hortobagyi T, Tunnerl D, Moody J, Beam S, DeVita P. Low- or high-intensity strength training partially restores impaired quadriceps force accuracy and steadiness in aged adults. J Gerontol Med Sci. 2001;56A: B38-B47.
87. 2max in men and women aged more than 65 years. J Gerontol Biol Sci. 2000;55A:B481-B488.
88. Jozsi AC, Campbell WW, Joseph L, Davey SL, Evans WJ. Changes in power with resistance training in older and younger men and women. J Gerontol Med Sci. 1999;54A:M591-M596.
89. Etnier JL, Salazar W, Landers DM, Petruzzello SJ, Han M, Nowell P. The influence of physical fitness and exercise upon cognitive functioning-a meta-analysis. J Sport Exercise Psychology. 1997;19:249-277.
90. Kramer AF, Hahn S, McAuley E. Influence of aerobic fitness on the neurocognitive function of older adults. J Aging Physical Activity. 2000;8:379-385.
91. McMorris T, Graydon J. The effect of incremental exercise on cognitive performance. Int J Sport Psychol. 2000;31:66-81.
92. Singh NA, Clements KM, Singh MAF. The efficacy of exercise as a long-term antidepressant in elderly subjects: a randomized, controlled trial. J Gerontol Med Sci. 2001;56A:M497-M504.
93. Keysor JJ, Jette AM. Have we oversold the benefit of late-life exercise? J Gerontol Med Sci. 2001;56A:M412-M423.
94. Smith JR, Olshansky SJ. Position statement on human aging [editorial]. J Gerontol Biol Sci. 2002;57A:B291.
95. Olshansky SJ, Hayflick L, Carnes BA. Position on human aging. J Gerontol Biol Sci. 2002;57A:B292-B297.